|
PNPT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79339987305127E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39570000001754E-08 |
| Normal-vs-Stage2 |
2.415700E-04 |
| Normal-vs-Stage3 |
1.03990005495547E-09 |
| Normal-vs-Stage4 |
5.43349809589699E-11 |
| Stage1-vs-Stage2 |
5.585200E-01 |
| Stage1-vs-Stage3 |
7.542000E-02 |
| Stage1-vs-Stage4 |
4.259700E-03 |
| Stage2-vs-Stage3 |
9.402400E-02 |
| Stage2-vs-Stage4 |
1.603510E-02 |
| Stage3-vs-Stage4 |
2.885600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.99199595391542E-11 |
| Normal-vs-AfricanAmerican |
1.621350E-03 |
| Normal-vs-Asian |
9.54699999999864E-05 |
| Caucasian-vs-AfricanAmerican |
3.246200E-01 |
| Caucasian-vs-Asian |
2.880200E-01 |
| AfricanAmerican-vs-Asian |
8.776200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27120003412529E-09 |
| Normal-vs-Female |
1.62400004555252E-09 |
| Male-vs-Female |
4.968400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.13559999959101E-07 |
| Normal-vs-Age(41-60Yrs) |
7.37020000585176E-10 |
| Normal-vs-Age(61-80Yrs) |
1.43689999898555E-08 |
| Normal-vs-Age(81-100Yrs) |
1.162310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.719900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.813400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.689800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.596800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.783400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.642600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.125580E-02 |
| Classical-VS-Follicular |
8.863600E-01 |
| Classical-VS-Other |
1.908820E-01 |
| Classical-VS-Normal |
7.49759998530664E-09 |
| Tall-VS-Follicular |
1.063850E-02 |
| Tall-VS-Other |
9.955400E-01 |
| Tall-VS-Normal |
7.20649995233913E-09 |
| Follicular-VS-Other |
6.123900E-02 |
| Follicular-VS-Normal |
2.45159999999744E-05 |
| Other-VS-Normal |
8.202000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.75799996571646E-09 |
| Normal-vs-N1 |
2.01410000011393E-07 |
| N0-vs-N1 |
4.547000E-01 |
|
|
